Grants and Contributions:
Title:
EUREKA – BREATHE: Biomarker-Guided Refinements of Lung Cancer Screening for Health Enhancement.
Agreement Number:
1031121
Agreement Value:
$499,800.00
Agreement Date:
May 12, 2025 - Feb 12, 2027
Description:
This project integrates multiple parameters into a risk-based model to improve the accuracy of early lung cancer detection and distinguish benign from malignant nodules.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4P5
Reference Number:
172-2025-2026-Q1-1031121
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
796635662
Recipient Type:
For-profit organization
Recipient's Operating Name:
Biomark Diagnostic Solutions inc.
Recipient's Legal Name:
Solutions de Diagnostic Biomark inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
621510